Aterian (NASDAQ:ATER – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.18) EPS for the quarter, topping the consensus estimate of ($0.58) by $0.40, Zacks reports. Aterian had a negative return on equity of 56.01% and a negative net margin of 17.05%. The business had revenue of $24.61 million for the quarter, compared to analyst estimates of $23.48 million. Aterian updated its FY 2025 guidance to EPS.
Aterian Price Performance
Shares of ATER stock opened at $2.70 on Thursday. The company has a market cap of $23.64 million, a price-to-earnings ratio of -0.99 and a beta of 2.03. The stock has a 50 day simple moving average of $2.20 and a 200-day simple moving average of $2.56. Aterian has a 1-year low of $1.86 and a 1-year high of $3.96.
Aterian announced that its board has approved a stock buyback program on Tuesday, March 18th that authorizes the company to repurchase $3.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 16.2% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its stock is undervalued.
Aterian Company Profile
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
See Also
- Five stocks we like better than Aterian
- What is a Bond Market Holiday? How to Invest and Trade
- Intel Stock Rallies on Leadership Change—Time to Buy or Wait?
- Stock Dividend Cuts Happen Are You Ready?
- 3 Semiconductor Stocks Flying Under the Radar—But Not for Long
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Despite Downturns, Analysts Say These 4 Financial Stocks Are Buys
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.